We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

148 hedge funds and large institutions have $753M invested in Viking Therapeutics in 2018 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 53 increasing their positions, 31 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 21

151% more capital invested

Capital invested by funds: $300M → $753M (+$453M)

71% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 31

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

28% more funds holding

Funds holding: 116 → 148 (+32)

7.55% more ownership

Funds ownership: 53.84% → 61.39% (+7.6%)

4% less call options, than puts

Call options by funds: $35.3M | Put options by funds: $37M

Holders
148
Holders Change
+32
Holders Change %
+27.59%
% of All Funds
3.38%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
54
Increased
53
Reduced
31
Closed
21
Calls
$35.3M
Puts
$37M
Net Calls
-$1.64M
Net Calls Change
-$3.74M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$86M
2
State Street
State Street
Massachusetts
+$63.3M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$13.7M
4
PWAM
Park West Asset Management
California
+$10.2M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$9.99M

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$42.4M
2
BC
Boxer Capital
California
-$35.6M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$13.9M
4
ACP
Acuta Capital Partners
California
-$7.12M
5
OM
Opaleye Management
Massachusetts
-$4.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
NC
26
Nexthera Capital
New York
$5.71M +$3.9M +327,730 New
Citigroup
27
Citigroup
New York
$5.69M +$3.78M +317,866 +3,515%
PC
28
Pier Capital
Connecticut
$5.32M -$3.27M -274,503 -47%
EI
29
EAM Investors
California
$4.86M -$1.08M -90,370 -24%
PM
30
Prosight Management
Texas
$4.78M +$3.27M +274,410 New
Russell Investments Group
31
Russell Investments Group
United Kingdom
$4.49M +$2.05M +172,572 +202%
American Century Companies
32
American Century Companies
Missouri
$4.42M +$3.02M +253,969 New
PPA
33
Parametric Portfolio Associates
Washington
$4.32M -$226K -19,012 -7%
DMK
34
David M. Knott
$4.12M -$119K -10,000 -4%
SCM
35
Sio Capital Management
New York
$3.71M -$810K -68,052 -24%
FPC
36
Falcon Point Capital
California
$3.64M +$2.28M +191,891 +1,134%
UBS Group
37
UBS Group
Switzerland
$3.59M +$1.48M +123,956 +151%
First Manhattan
38
First Manhattan
New York
$3.52M -$3.96M -332,900 -62%
RSCM
39
Rock Springs Capital Management
Maryland
$3.48M +$2.38M +200,000 New
CC
40
Cornerstone Capital
California
$3.14M +$412K +34,621 +24%
MIM
41
Monashee Investment Management
Massachusetts
$3.14M – – –
SM
42
Sabby Management
Florida
$2.85M +$1.95M +163,463 New
Morgan Stanley
43
Morgan Stanley
New York
$2.76M +$719K +60,414 +62%
HVC
44
Healthcare Value Capital
New Jersey
$2.61M – – –
Barclays
45
Barclays
United Kingdom
$2.59M -$1.07M -90,224 -38%
Allianz Asset Management
46
Allianz Asset Management
Germany
$2.52M +$1.72M +144,432 New
RJA
47
Raymond James & Associates
Florida
$2.49M +$1.7M +143,147 New
EAM
48
Eagle Asset Management
Florida
$2.28M +$632K +53,076 +68%
Jane Street
49
Jane Street
New York
$2.23M +$1.52M +128,065 New
TA
50
Teachers Advisors
New York
$2.22M +$523K +43,960 +53%
1
2
3 4 5

VKTX Hedge Fund Activity: Q3 2018 in Review

148 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q3 2018, worth a combined $753M — up 151% from $300M a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new VKTX positions and 21 closed out — a net gain of 33 holders — while 53 added to existing stakes and 31 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $86M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $42.4M sold.

  • 148 institutional investors held Viking Therapeutics (VKTX) as of Q3 2018, up from 116 in Q2 2018.
  • Funds reported $753M of Viking Therapeutics stock for Q3 2018, up 151% quarter-over-quarter.
  • 54 funds opened new Viking Therapeutics positions in Q3 2018 and 21 closed out, a net change of +33 holders.
  • The largest Viking Therapeutics buyer in Q3 2018 was Fidelity Investments, an estimated $86M added.
  • The largest Viking Therapeutics seller in Q3 2018 was Avoro Capital Advisors, an estimated $42.4M sold.

Based on aggregated 13F filings for Q3 2018.